EP2445485A1 - Chewable drug - Google Patents
Chewable drugInfo
- Publication number
- EP2445485A1 EP2445485A1 EP09827025A EP09827025A EP2445485A1 EP 2445485 A1 EP2445485 A1 EP 2445485A1 EP 09827025 A EP09827025 A EP 09827025A EP 09827025 A EP09827025 A EP 09827025A EP 2445485 A1 EP2445485 A1 EP 2445485A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- drug
- chewable
- candy
- delivery system
- supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
Definitions
- This invention relates to a chewable drug, and more particularly, to a chewable delivery system for the delivery of pharmaceutical compounds, and a method for manufacturing the same.
- OTC Over-the-counter
- prescription drugs play a vital role in America's health care system. While both are regulated by the U.S. Food and Drag Administration (FDA), OTC drag products are available to consumers without a prescription. There are more than 80 therapeutic categories of OTC drags, ranging from acne drags products to weight control products, and more than 100,000 OTC drag products are currently sold in this country. OTCs are critical to our country's health care system because they provide easy access to certain drags that can be used safely without the help of a health care practitioner.
- FDA U.S. Food and Drag Administration
- Drags that are taken orally generally come in the form of a liquid, a tablet, a pill, or a capsule. In many cases, this is not an enjoyable experience because the pharmaceuticals are either difficult to ingest due to size or texture, or are not palatable.
- gummy candy is made from a gelatin base — which is similar to the base found in soft caramels, marshmallows, foam-filled wafers, licorice, wine gums, pastilles, chocolate coated mallows and a host of other sweets — and a blend of corn starch, corn syrup, sugar, color, and flavor. Gelatin gives the candy its elasticity, the desired chewy consistency, and a longer shelf life.
- a chewable composition for delivering pharmaceutical compounds is provided.
- the chewable composition generally includes a binding agent, a sweetener, and a pharmaceutical compound.
- the chewable composition includes a drug delivery system for delivering pharmaceutical compounds to a user's body.
- the drug delivery system includes a drug delivery vehicle in the form of a gummy candy, and a pharmaceutical compound as a primary active ingredient of the gummy candy.
- the delivery vehicle may include a non-organic or an organic gummy candy.
- the gummy candy may include sweeteners, a binding agent, and natural and/or artificial flavors, colors, and preservatives.
- the gummy candy may include glucose syrup, natural cane juice, gelatin, citric acid, lactic acid, natural colors, natural flavors, fractionated coconut oil, and carnauba wax.
- the primary active ingredient may include an OTC or a prescription drug to provide a desired effect on the user.
- the drug delivery system may also include nutraceuticals (i.e., extracts of food purported to have a medicinal effect on human health) such as botanical and herbal extracts and antioxidants, or any combination of food supplements such as vitamins, minerals, soluble and insoluble fiber, herbs, plants, amino acids, and digestive enzymes.
- a method of preparing a chewable drug includes mixing a binding agent with water to form a gelling compound, adding a desired dosage of a pharmaceutical compound to the gelling compound, and adding a sweetener to the gelling compound. After the sweetener is added to the gelling compound, the compound is cooked to form a cooked candy, and then flavoring may be added to the cooked candy. After the flavoring is added, the cooked candy is molded and cured until a chewable drug is formed.
- FIG. 1 shows a flow diagram of an example of a method of manufacturing a chewable drug of the present invention.
- FIG. 2 shows a flow diagram of an example of a method for incorporating a pharmaceutical compound into a delivery vehicle of a drug delivery system of the present invention.
- the present invention relates to a chewable drug, in particular, a delivery system that is chewy or gummy-like and designed to enhance the delivery of pharmaceutical compounds.
- the delivery system includes a primary active ingredient to provide a desired effect, and a chewable delivery vehicle to contain the active ingredient for delivery.
- the primary active ingredient of the present invention may include a pharmaceutical compound.
- the pharmaceutical compound may include an OTC drug to treat symptoms of common illnesses.
- OTC drugs may include Benadryl®, Sudafed®, Claritin®, Maalox®, Mylanta®, Insulin, Turns®, Pepcid® AC, Monistat®, Ex-Lax®, Imodium® A.D., Robitussin®, Chloraseptic®, Thera-flu®, Alka-Seltzer, Motrin®, Dramamine®, and the like, in liquid or powder form.
- the pharmaceutical compound may include a prescription drug.
- Such prescription drugs such may include Lipitor®, Singulair®, Lexapro, Plavix®, Morphine, Hydrocodone (Vicodin®), Demerol®, Codeine, Diazepam (Valium®), Penicillin, Prevacid®, Allegra-D®, Celebrex®, Crestor®, Cialis®, Valtrex®, Ambien CR®, Viagra®, Flomax®, Prozac®, and the like, in liquid or powder form.
- pharmaceutical compounds are generally expressed in terms of grams or milligrams, but may also be expressed in active units, or international unit (IU).
- a "pharmaceutical compound” or “drug” shall include, but is not limited to, any drug, hormone, peptide, nucleotide, antibody, or other chemical or biological substances used in the treatment or prevention of disease or illness, or substances which affect the structure or function of the body.
- the delivery system may also include any combination of vitamins, minerals, antioxidants, soluble and insoluble fiber, herbs, plants, amino acids, digestive enzymes, or any other supplements digested to promote the heath and well-being of a person. Inclusion of any of these dietary supplements will depend in part on their compatibility with the pharmaceutical compound.
- the primary active ingredient is delivered in a delivery vehicle that is palatable and easy to swallow.
- the delivery vehicle may be a gummy candy to facilitate swallowing.
- the delivery vehicle may include a binder, sweeteners, and flavoring.
- the delivery vehicle may further include coloring and preservatives.
- the first phase of mixing and storing begins with step 110, where water and a binding agent are mixed in a mixing tank to form a gelling compound.
- the mixing tank may include a 1,000 gallon stainless steel planetary mixer, a scrape surface mixer, a holding tank with an agitator, or any other suitable mixer.
- water and the binding agent are continuously mixed in the mixing tank and the gelling compound is continuously turned in the tank by an agitator to keep the binding agent suspended in water (i.e., to prevent the binding agent from settling on the bottom of the mixing tank).
- an agitator to keep the binding agent suspended in water (i.e., to prevent the binding agent from settling on the bottom of the mixing tank).
- approximately 6,000 lbs to 8,000 lbs of gelling compound may be produced in 8 hours.
- the gelling compound may include cold, warm, or hot water. However, warm or hot water may be used to reduce the hydration time (i.e., the time it takes the water to hydrate the binding agent) of the gelling compound. For example, about 250 lbs of gelatin mixed with about 250 lbs of warm water may reach a homogenous mixture in about 10 minutes. The hydration rate of the gelling compound may also vary according to the speed of the agitator.
- the binding agent may include a pectin gel, gelatin, food starch, or any combination thereof. Depending on the binding agent used, the gelling compound may include, for example only, one of the following formulations: Table A
- Binding Agent (% by weight) Water (% by weight) gelatin 50% 50% pectin 2%-3% 97%-98% starch 7%-10% 90%-93% pectin/starch 8%- 10% ( 1 %-2% pectin / 7%-8% starch) 90%-92%
- a buffer such as sodium bisulfate or sodium citrate, may be
- the gelling compound may contain approximately 0.01 to 0.03% buffer by weight, or any other
- the pH of the mixing tank may be adjusted to a range from about 3.2 to about 4.5 to provide adequate gelation and to ensure that the gelling compound does not become unstable (or acidic) during mixing.
- the gelling compound may be filtered through a fine mesh, to remove particulates in the slurry, and stored in a holding tank. In one implementation, about 140 lbs to
- 190 lbs of gelling compound may be delivered from the mixing tank to the holding tank every 5 to 10 minutes.
- the filter may be a 0.034 inch stainless steel basket strainer and the holding tank may be a 1,500 gallon stainless steel tank.
- the holding tank may be a 0.034 inch stainless steel basket strainer and the holding tank may be a 1,500 gallon stainless steel tank.
- the holding tank may be a 0.034 inch stainless steel basket strainer and the holding tank may be a 1,500 gallon stainless steel tank.
- the holding tank may
- moderate agitator e.g., mixing blades
- the mixing vessel may be a 5,000 gallon stainless steel planetary mixer.
- the mixing vessel may be a scrape surface mixer, a holding tank with an agitator, or any other type of suitable mixer.
- water, additives, supplements, and an active ingredient may be used in the mixing vessel.
- the additives may include sodium citrate, sweeteners such as sugar (also referred to herein as sucrose or natural
- the supplements may include vitamins, minerals, herbs,
- the supplements may include, but not be limited to, any of the following:
- Vitamin B2 (Riboflavin)
- Vitamin B3 (Niacinamide)
- Vitamin B5 Purothenic Acid
- Vitamin B6 (Pyridoxine HCL)
- Vitamin C Ascorbic Acid/ Activated C
- Vitamin D (Cholecalciferol)
- Vitamin K (Phytonadione)
- the sugar slurry may contain approximately 70% to 85%
- the sweetener by weight, while the remaining approximately 15% to 30% of the slurry (by weight) may contain the gelling compound and additives. More particularly, the slurry may contain
- the candy slurry may reach a homogeneous mixture in about 5 to 10 minutes.
- the ingredients and the composition of the sugar slurry may vary based on the type of formulation desired.
- corn starch may be added to the sugar slurry in an implementation where pectin is added to the gelling compound, to stabilize the product; or, to reduce production cost, the sweetener may include a combination of natural cane juice (sugar) and syrup.
- syrup may also be used to temper the resulting candy.
- the sugar and syrup additives Prior to production, the sugar and syrup additives may be stored in bulk tanks. In one implementation, the syrup may be stored in a holding tank at a temperature of approximately 75° F.
- the syrup may be irradiated by ultraviolet light to remove any contaminants in the syrup.
- the syrup may include high fructose corn syrup (e.g., HFCS-42, HFCS-55, or HFCS-62), glucose syrup, rice syrup, tapioca syrup, or any other suitable liquid sweetener or combination thereof.
- HFCS-42, HFCS-55, or HFCS-62 high fructose corn syrup
- glucose syrup e.g., HFCS-42, HFCS-55, or HFCS-62
- glucose syrup e.g., HFCS-42, HFCS-55, or HFCS-62
- glucose syrup e.g., HFCS-55, or HFCS-62
- the syrup may be administered to the mixing vessel manually or by automation.
- sugar may be stored in a holding tank.
- sugar may be fed through an automated feed system that filters the sugar to remove any sediments, weighs the sugar, and delivers a desired quantity of sugar to the mixing vessel.
- sugar may be added to the mixing vessel manually.
- the sugar slurry is processed through a magnetic device, which removes particulates from the slurry, and stored in a storage buffer tank at step 116.
- the magnetic device may be a finger magnet or any other suitable magnetic device
- the storage tank may be a 5,000 gallon stainless steel industrial holding tank.
- the holding tank may include a moderate agitator to suspend the active ingredients in the sugar slurry.
- the sugar slurry Prior to reaching the storage buffer tank, the sugar slurry may be heated through a series of heat exchangers to a temperature of approximately 150° F to 180° F.
- the storage buffer tank may receive the candy slurry from the mixing vessel at a mass flow rate of approximately 15 lbs/s to 20 lbs/s, and maintain the slurry at a temperature of approximately 150° F to 200° F. Simultaneously, the warm candy slurry may be continuously fed from the storage buffer tank to a static cooker at mass flow rate of approximately 10 lbs/s to 15 lbs/s, by way of example only.
- the candy slurry mix is received by the static cooker and cooked at a temperature of approximately 220° F to 260° F for approximately 30 sec. to 60 sec, until the slurry is gelatinized (i.e., dehydrated).
- the static cooker may be a 2,500 gallon high pressure steam jacketed kettle, a vacuum pressure cooker, or any other suitable cooker.
- moisture is evaporated out of the candy slurry as the slurry is boiled to a temperature of approximately 250° F.
- the slurry may consist of about a 65 to 75 brix solution (i.e., the slurry may consist of approximately 65 grams to 75 grams of sugar per 100 grams of solution).
- the cooked candy is then delivered to a vacuum chamber at step 120.
- the vacuum chamber may be a 50 psi industrial vacuum chamber or any other suitable enclosure.
- the pressure cooker may also include a vacuum apparatus.
- moisture is drawn from the cooked candy by suction pressure.
- the vacuum chamber may draw out approximately 2% to 5% water by weight.
- the cooked candy may have a brix of approximately 67 to 80, and a pH of approximately 2.8 to 4.0, for example.
- the cooked candy is filtered into a trough, commonly known as a dosier.
- the filer may be a 0.034 inch basket strainer.
- the cooked candy mainly consists of a clear sugar gelatin. To obtain a desired color and taste, coloring and flavoring may now be added to the cooked candy.
- the cooked candy may be passed through the dosier.
- water, flavoring, coloring, and food acid may be added to the cooked candy to enhance the candy's taste.
- flavoring such as artificial and/or natural flavoring (e.g., fruit concentrate) may be added to the cooked candy to give the candy a desired flavor.
- food acid may be added to the cooked candy.
- Such food acids may include citric acid, ascorbic acid, malic acid, lactic acid, adipic acid, fumaric acid, tartaric acid, or any other suitable food acid or combinations thereof.
- the flavoring, coloring, and acid may be continuously added to (e.g., dripped on) the cooked candy as the candy moves through the dosier to the mogul machine.
- the amount of flavoring, coloring, and acid administered to the cooked candy may vary according the volume of cooked candy passing through the dosier and the desired candy formulation. For example, in one implementation, approximately 1 % to 2% flavoring by weight and approximately 0.01 % to 0.03 % acid by weight may be added to the cooked candy composition. However, the amount of acid and flavoring added to the cooked candy formulation must be balanced to insure that the cooked candy will taste good. So, depending on the formulation, more flavoring and less acid may need to be added to the cooked candy for bitter formulations. In some instances, only food acid instead of flavoring may be added the cooked candy.
- coloring and titanium dioxide may be added to the cooked candy formulation in the dosier. Coloring may be added to give the candy a desired color or colors. Coloring may include natural coloring such as black carrot, annatto, tumeric, and purple berry concentrate, or artificial coloring such as yellow 5, red 3, and blue 1.
- Titanium dioxide may be added to the candy to provide sheen. Titanium dioxide may also stabilize the cooked candy formulation so the coloring does not bleed when it is handled, packaged, or stored.
- the candy may be sent to a starch molding machine at step 130.
- the starch molding machine may include a mogul machine (simply referred to as a "mogul").
- a mogul is a starch molding machine that deposits the cooked candy, or gummi stock, onto starch covered mold boards ("mogul boards") that allow the cooked candy to firm and take on the shape of the mold, to produce a series of shaped gummy candies.
- the mogul boards are usually covered with starch to prevent the gummi stock from sticking to the mogul boards.
- the starch used to coat the mogul boards may include recirculated starch prepared from re-used starch that is sifted and dried in a starch dryer, and then cooled in a starch cooler. The cooled starch is sifted again and placed in the mogul where it is recirculated through the same process. The recirculated starch may then be sprayed evenly on the mogul board. The cooked candy may then be deposited onto mogul boards coated with the recirculated starch.
- the cooked candy is placed on the mogul boards, the cooked candy is placed in a temperature and humidity controlled curing room, where the candy sits and cools (i.e., is cured) for approximately 24 hours to 48 hours (step 132). Proper curing time is necessary to ensure sugar, oil, or wax coating and ease of packaging without breakage and proper yield.
- the candy may be cured in a curing room with approximately 15% to 25% humidity.
- the gummy candies may be removed from the mogul boards and dumped into a tumbler machine at step 134.
- the tumbler may be a 2,000 gallon rotating drum, hi the tumbler, the gummies may be tumbled together to remove any starch remaining on the gummy candies. Once the starch is removed, the gummies may become sticky, so the gummies may be polished or coated with oil to prevent the cooked candies from sticking together.
- the gummies may be polished with fractionated coconut oil, linsic oil, bees wax, carnauba wax, or any other suitable food grade oil.
- the gummies may be sanded with sugar in a sugar drum.
- a cooling belt e.g., a conveyor belt
- the gummy candies are placed on an inspector belt where the candy is inspected for food safety and proper organoleptic effects.
- the gummy candies may be passed by a detector or x-ray to insure that no particulate or other foreign material has been deposited into the candy during the depositing stage.
- step 138 once the candy passes inspection, the finished gummy product is packaged for distribution.
- Pharmaceutical compounds may be incorporated into a delivery system of the present invention by one of three methods: (i) as a liquid or solid prior to cooking the gummy composition; (ii) by encapsulation; or (iii) in liquid or extract form after the gummy composition has been cooked.
- the manner in which a pharmaceutical is incorporated into the delivery system depends on the heat sensitivity and chemical composition of the drug.
- a drug may be added to the gelling compound at step 114 (FIG. 1), during the mixing and storing phase.
- the drug may be poured into the mixing vessel in solid, powdered or liquid form.
- this method may not be effective for heat-sensitive drugs.
- the gelling compound may be heated to a temperature of 185° F.
- the chemical structure of a drug incorporated into the delivery system under this method must be able to withstand temperatures in excess of 200° F.
- the second method of encapsulation may be applied. Under this second method, the drug may be encapsulated before it is added to the gelling compound at step 114 (FIG. 1). This method may be most effective for drugs, in solid or powdered form, that are moderately resistant to heat.
- the drug Prior to encapsulation, the drug may be pulverized to within a discrete particle size ranging from approximately 10 microns to 300 microns; the smaller the particle size, the more effective the encapsulation. Because the drug is encapsulated, the drug release and absorption capabilities of the delivery system may be controlled depending on the effectiveness of the encapsulation. For example, encapsulation may prevent early release of the drug to the user's system.
- a solvent system containing a filming agent may be mixed with the drug particles and blended at slow speed in a planetary mixer.
- the solvent may be water or ethanol and the filming agent may be ethylcellulose, gelatin, a water-soluble plasticizer (e.g., glycerin, xylitol, or glucose), or any other suitable composition.
- the filming agent solution may be slowly added to the drug particles so that enough individual particles will adhere together to form larger granules having a size of approximately 300 to 500 microns.
- the degree of encapsulation may vary depending upon the number of layers of filming agent solution applied.
- the film coating may have a thickness of about 1 micron or less.
- heat sensitive drugs may be added to the cooked candy at step 122, during the flavoring and coloring phase.
- a drug in liquid or extract form may be added to the cooked candy in the dosier with the coloring and/or flavoring. While in other implementations, the drug may be added in solid or powdered form, drugs in the form of liquid or extracts are preferred at this stage of the manufacturing process because liquids and extracts are better absorbed by the cooked candy.
- the amount of flavoring added to the cooked candy will vary depending upon the desired flavor and amount of pharmaceuticals added to the gelling compound. Some pharmaceuticals will require differing amounts of flavor, sweetener, color, and citric acid to create a desirable tasting chewable drug. For example, to mask the flavor of a particular drug, a flavoring agent such as strawberry flavor or cherry flavor may be added to the mixture. The additional flavor would be adjusted based upon the drug. For extra bitter drugs, a flavor masking flavor compound from flavor houses may also be utilized.
- the first step is to prepare a test batch of gummy candies adding the drug to the gelling compound in the mixing vessel, at step 114 (FIG. 1) of the manufacturing process.
- the candies may be inspected and tested at step 136 (FIG. 1) to validate that the drug composition of the candies meet the desired label requirements (i.e., meet the dosage printed on the product label).
- the chemical formulation of the finished gummy product is set and the gummy candies may be mass produced and packaged using the first method of incorporation described above.
- a second test batch may be produced and tested. This time, the dosage of the drug added to the gelling compound at step 114 (FIG. 1) may be increased to compensate for the drugs broken down during the cooking phase (step 220).
- the mixing weigh vessel For example, if 100 mg of aspirin is added to the gelling compound in the mixing weigh vessel to produce a 75 mg drug, but only 50 mg of aspirin is measured in the finished product, then 150 mg of aspirin may be added to the gelling compound in the mixing weigh vessel during the second production to compensate for the 25 mg of aspirin dissipated during the manufacturing process.
- the drug composition is validated, then the chemical formulation of the finished gummy product is set and the gummy candies may be mass produced and packaged using the first method of incorporation described above. However, if second batch does not meet the label requirements, the drug may need to be encapsulated or added at a different stage of the manufacturing process.
- a third test batch of gummy candies may be produced (step 230).
- the encapsulated drug may be added to the gelling compound in the mixing vessel, at step 114 (FIG. 1) of the manufacturing process, and the gummy candies are tested once again. If the gummy candies meet the label requirements, then the chemical formulation will be set (with an encapsulated drug), and the gummies may be mass produced and packaged using the second method of incorporation described above.
- step 240 the drug may need to be incorporated into the cooked candy as an oil, extract, or liquid in the flavoring and coloring phase of the manufacturing process.
- a fourth test batch may be produced where a liquid or extract drug may be added to the cooked candy with the coloring and flavoring at step 122 of the manufacturing process.
- the batch may be tested once again to validate the drug composition of the candies. If the drug composition is validated, then the chemical formulation of the gummy product is set and the gummy candies may be mass produced and packaged using the third method of incorporation described above. If the third batch does not meet the label requirements, the dosage of the liquid or extract may need to be adjusted accordingly at step 122 (FIG. 1).
- Chewable drugs of the present invention may include non-organic and/or organic compositions.
- the chewable drug may include a non-organic or an organic gummy candy. While the process of
- the delivery system of the present invention may include a non-organic gummy.
- a 50 mg non-organic chewable aspirin in accordance with the present invention may be prepared using the following formula:
- about 50 lbs of warm water may be mixed with about 50 lbs of gelatin in the mixing tank, to form 100 lbs of gelling compound having a homogeneous 50/50 blend of water and gelatin. While gelatin is described as the binding agent in this specific
- pectin for example, pectin, food starch, gum, or any combination thereof may be used as the binding agent in other implementations.
- About 0.1% to 10% of sodium bisulfate by weight may be added to
- the gelling compound to reduce the pH of the gelling compound to about 3.5.
- the gelling compound may be mixed with about 6 lbs of water, 38.3 lbs of sucrose, and 50 lbs of corn syrup to form the candy slurry. Because aspirin is
- step 114 (FIG. 1).
- about 0.1% sodium citrate by weight may also be added to the candy slurry
- the candy slurry may be heated to a temperature of about 180° F prior to being passed through the storage buffer tank, to the static cooker.
- the candy slurry may be heated to a temperature of about 240° F to 245° F, dehydrating the slurry to a brix of
- the cooked candy is sent to the vacuum chamber, where
- the candy may be further dehydrated to a brix of about 80. After leaving the vacuum, the cooked candy
- candy is placed in the dosier where about 1.5% of strawberry flavoring by weight and about 1% of red cabbage coloring by weight may be added to the cooked candy. To balance the flavoring,
- citric acid by weight and about 0.1% lactic acid by weight may be added to the
- the cooked candy may be deposited into the cooked candy
- the mogul machine and then cured. After the candies are cured, they may be added to a tumbling drum to break off any starch that may be remaining on the candies. As the candies are being tumbled, about 1% fractionated coconut oil by weight and about 1% carnauba wax by weight may be poured into the drum to coat the candies to prevent them from sticking together.
- the candies After the candies are coated, they may be inspected to validate that the finished product meets the label requirements, and then packaged.
- the delivery system of the present invention may include
- ingredients used to form the drug must meet the requirements for organic certification.
- these ingredients may include, but not be limited to, pectin, organic evaporated cane juice, organic tapioca syrup, organic grape juice,
- citric acid lactic acid, sodium citrate
- natural color e.g., black carrot, juice concentrate, annatto, turmeric, purple berry concentrate
- natural flavor e.g., strawberry, orange, pineapple, grape
- a proprietary blend of vitamins, minerals and other functional ingredients e.g., strawberry, orange, pineapple, grape
- an organic chewable drug containing 2 mg of Valium® in accordance with the present invention, may be prepared using the following formula:
- pectin is described as the binding agent in this specific example, gelatin and a combination of pectin and food starch may also used as the binding agent in other
- the gelling compound may be mixed with 6 lbs of water, 43.49 lbs of organic sugar, and 50 lbs of organic tapioca syrup to form the candy slurry. Because
- Valium® is not a heat sensitive drug, about 0.08 lbs to 0.1 lbs of Valium® may be added to the candy slurry at step 114 (FIG. 1). About 0.1% sodium citrate by weight may also be added to the candy slurry to maintain the pH of the slurry at about 3.0 to 3.5.
- the candy slurry may be heated to a temperature of about 180° F prior to being passed through the storage buffer tank, to the static cooker.
- the candy slurry may be heated to a temperature of about 240° F to about 245° F, dehydrating the slurry to a brix of about 78.
- the cooked candy is sent to the vacuum chamber, where the candy may be further dehydrated to a brix of about 80. After leaving the vacuum, the cooked candy is placed in the dosier where about 1.5% natural apple and cherry flavoring by weight and 1% tumeric and black hair juice coloring by weight may be added to the cooked candy. To balance the flavoring, about 0.1% citric acid by weight and about 0.1% lactic acid by weight may be added to the cooked candy.
- the cooked candy may be deposited into the mogul machine and then cured. After the candies are cured, they may be added to a tumbling drum to break off any starch that may be remaining on the candies. As the candies are being tumbled, about 0.08% to 0.1% sugar by weight may be added to coat the candies. [0081] After the candies are coated, they may be inspected to validate that the finished product meets the label requirements, and then packaged.
- organic gummies having a pectin base produce a gummy candy that is both elastic and has a slightly brittle gel texture with a brilliant fracture. Due to the differing properties between pectin and gelatin, different challenges are present during the manufacturing of pectin-based gummy candies. However, due to the
- drugs provided in a pectin-based delivery system may be more easily and quickly digested over non-organic gummies, resulting in a more desirable drug delivery system.
- the delivery system of the present invention may include a pure starch-based gummy.
- Prilosec OTC® in accordance with the present invention, may be prepared using the following
- the starch compound in the mixing tank, to form 100 lbs of gelling compound having a homogeneous 91/9 blend of water and starch.
- the starch compound may be corn starch, rice starch, modified starches, or any other suitable starch compound.
- About 0.1% to 10% of sodium bisulfate by weight may be added to the gelling compound to reduce the pH of the gelling compound to about 3.5.
- the gelling compound may be mixed with about 6 lbs of water, 37.46 lbs of sucrose, and 49 lbs of corn syrup to form the candy slurry. About 0.03 lbs to
- Prilosec OTC® may be added to the candy slurry at step 114 (FIG. 1).
- About 0.1% sodium citrate by weight may also be added to the candy slurry to maintain the pH of the slurry at about 3.0 to 3.5.
- the candy slurry may be heated to a temperature of about 180° F prior to being passed through the storage buffer tank, to the static cooker.
- the candy slurry may be heated to a temperature of about 240° F to 245° F, dehydrating the slurry to a brix of about 78.
- the cooked candy is sent to the vacuum chamber, where the candy may be further dehydrated to a brix of about 80. After leaving the vacuum, the cooked candy is placed in the dosier where about 1.5% of orange and cherry flavoring by weight and about 1% of annatto and tumeric coloring by weight may be added to the cooked candy. To balance the flavoring, about 0.1% citric acid by weight and about 0.1% lactic acid by weight may be added to the cooked candy.
- the cooked candy may be deposited into the mogul machine and then cured. After the candies are cured, they may be added to a tumbling drum to break off any starch that may be remaining on the candies. As the candies are being tumbled, about 1% fractionated coconut oil by weight and about 1% carnauba wax by weight may be poured into the drum to coat the candies to prevent them from sticking together. [0089] After the candies are coated, they may be inspected to validate that the finished product meets the label requirements, and then packaged.
- Starch-based gummies provide an additional benefit over gelatin-based gummies.
- gelatin-based gummies because gelatin liquefies when heat is applied, gelatin-based gummies frequently melt when they are exposed to high temperatures during storage and transport.
- starch is more stable than gelatin in high temperatures. This is because the semi-crystalline structure of starches do not fully recover once a starch is gelatinized (i.e., becomes a gel when cooked in water) and then cooled, so the starch becomes a thickened paste. If additional heat is applied to the thickened paste, the starch will not liquefy since the starch granules swell and burst during the gelatinization process. Thus, starch-based gummies may retain their gummy shape under high temperature without melting. This is ideal for gummies that are exposed to high temperatures during storage and transport.
- Formulations for chewable drugs of the present invention may vary based on the desired dosage of the active pharmaceutical ingredients and the amount of additives, sweeteners, and coloring added to the drug composition. Thus, testing will be required to arrive at a suitable composition for each chewable drug.
- implementations of the invention have been described with reference to a gummy delivery system, the invention is not limited to this application and may be readily used for any chewable composition that includes a pectin, gelatin, or starch base.
- implementations of the invention may also be employed in organic tablets, capsules, or solid candies.
- the present invention may also apply to other forms of candies such as jelly beans or caramel-based candies.
- the dimensions of the holding and mixing vessels are provided herein by way of example only, the actual dimensions of these vessels may vary based on the amount of gelling compound and candy slurry produced in a given time period (e.g., per day).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22011109P | 2009-06-24 | 2009-06-24 | |
US12/547,355 US20100330058A1 (en) | 2009-06-24 | 2009-08-25 | Chewable drug |
PCT/US2009/055041 WO2010151275A1 (en) | 2009-06-24 | 2009-08-26 | Chewable drug |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2445485A1 true EP2445485A1 (en) | 2012-05-02 |
EP2445485A4 EP2445485A4 (en) | 2013-08-28 |
Family
ID=43381015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09827025.9A Withdrawn EP2445485A4 (en) | 2009-06-24 | 2009-08-26 | Chewable drug |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100330058A1 (en) |
EP (1) | EP2445485A4 (en) |
BR (1) | BRPI0925056A2 (en) |
CA (1) | CA2766908A1 (en) |
MX (1) | MX2012000132A (en) |
WO (1) | WO2010151275A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014227406A (en) * | 2013-05-27 | 2014-12-08 | 株式会社ウメケン | Bitter crude drug-comprising granular product |
ES2744435T3 (en) | 2013-09-30 | 2020-02-25 | Iaf Science Holdings Ltd | Chewable product and procedure to prepare it |
CN107613789A (en) | 2015-04-07 | 2018-01-19 | 丘奇和德怀特有限公司 | Multicomponent fondant composition with soft core |
WO2017137992A1 (en) | 2016-02-11 | 2017-08-17 | Gelpell Ag | Oral solid cannabinoid formulations, methods for producing and using thereof |
JP6877923B2 (en) * | 2016-09-06 | 2021-05-26 | ライオン株式会社 | Semi-solid preparation for internal use and its manufacturing method |
US10960076B2 (en) | 2017-01-25 | 2021-03-30 | Church & Dwight Co. Inc. | Gummy dosage forms comprising serine |
GB201801994D0 (en) * | 2018-02-07 | 2018-03-28 | Ubeauty Global | A tanning composition |
US11273123B2 (en) | 2018-07-18 | 2022-03-15 | USpharma Ltd | Chewable pharmaceutical dosage forms |
US12390416B2 (en) | 2018-07-18 | 2025-08-19 | USpharma Ltd | Chewable pharmaceutical dosage forms |
US11350657B2 (en) | 2018-08-06 | 2022-06-07 | Pharmavite, Llc | Protein gummy composition |
US20220339097A1 (en) | 2021-04-27 | 2022-10-27 | Gelita Ag | Discontinuous gummy delivery systems |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4950689A (en) * | 1987-03-31 | 1990-08-21 | Yang Robert K | Pectin delivery system |
US4800096A (en) * | 1987-05-29 | 1989-01-24 | General Foods Corporation | Pectin gelling composition |
JP3618355B2 (en) * | 1995-12-26 | 2005-02-09 | オネスタ・ニュートリション・インコーポレーテッド | Dietary fiber delivery system |
US6929807B1 (en) * | 1996-08-09 | 2005-08-16 | Mannatech, Inc. | Compositions of plant carbohydrates as dietary supplements |
US6027746A (en) * | 1997-04-23 | 2000-02-22 | Warner-Lambert Company | Chewable soft gelatin-encapsulated pharmaceutical adsorbates |
US6241997B1 (en) * | 1998-03-16 | 2001-06-05 | Smtm Group. Llc | Chewable calcium supplement and method |
US5955102A (en) * | 1998-09-04 | 1999-09-21 | Amway Corporation | Softgel capsule containing DHA and antioxidants |
US6193999B1 (en) * | 1999-03-01 | 2001-02-27 | Banner Pharmacaps, Inc. | Gum acacia substituted soft gelatin capsules |
US6340471B1 (en) * | 1999-12-30 | 2002-01-22 | Alvin Kershman | Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
JP2001342127A (en) * | 2000-06-02 | 2001-12-11 | Nomoto Kikuo | Intestinally absorbable antiinflmmatory factor- containing immunological substance and application thereof |
US7438936B2 (en) * | 2000-06-12 | 2008-10-21 | Access Business Group International Llc | Dietary supplement and related method |
US20070292517A1 (en) * | 2004-04-01 | 2007-12-20 | Scepter Holdings, Inc. | Delivery Systems for Antacids |
US20070269386A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
-
2009
- 2009-08-25 US US12/547,355 patent/US20100330058A1/en not_active Abandoned
- 2009-08-26 CA CA2766908A patent/CA2766908A1/en not_active Abandoned
- 2009-08-26 BR BRPI0925056A patent/BRPI0925056A2/en not_active IP Right Cessation
- 2009-08-26 WO PCT/US2009/055041 patent/WO2010151275A1/en active Application Filing
- 2009-08-26 MX MX2012000132A patent/MX2012000132A/en not_active Application Discontinuation
- 2009-08-26 EP EP09827025.9A patent/EP2445485A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2445485A4 (en) | 2013-08-28 |
CA2766908A1 (en) | 2010-12-29 |
MX2012000132A (en) | 2012-05-08 |
US20100330058A1 (en) | 2010-12-30 |
BRPI0925056A2 (en) | 2015-11-24 |
WO2010151275A1 (en) | 2010-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100226904A1 (en) | Organic chewable supplement | |
US20100330058A1 (en) | Chewable drug | |
US20120164134A1 (en) | Sugar-free chewable supplement | |
US11172690B2 (en) | Enclosing materials in natural transport systems | |
US20120035277A1 (en) | Liquid-filled chewable supplement | |
US7067150B2 (en) | Delivery systems for functional ingredients | |
US20070196496A1 (en) | Delivery systems for functional ingredients | |
US20120015075A1 (en) | Chewable supplement with live microorganisms | |
US20110071119A1 (en) | Heat resistant delivery system | |
WO2012092391A1 (en) | Method for adding heat sensitive ingredients to chewable supplements | |
AU2003213912A1 (en) | Delivery systems for functional ingredients | |
WO2012173587A1 (en) | Sugar-free chewable supplement | |
US20130004604A1 (en) | Dark chocolate delivery system for a combination of dietary supplements and pharmaceuticals | |
CN112770733A (en) | Chewable tablet and preparation method thereof | |
WO2019070818A2 (en) | Suspensions of encapsulated pharmaceuticals and methods of making and using the same | |
WO2013163240A1 (en) | Center-in-shell chewable compositions with functional components | |
EP2352491A2 (en) | Plant-based granules | |
EP4366697A1 (en) | Gummy dosage forms | |
CA2772231A1 (en) | Chocolate delivery system for pharmaceuticals and nutraceuticals | |
EP4593797A1 (en) | Gummy dosage forms | |
JP2002193791A (en) | Method of producing shogenshaku granular preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100526 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: HERO NUTRITIONAL PRODUCTS, LLC |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130729 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23L 1/05 20060101ALN20130722BHEP Ipc: A23L 1/29 20060101ALN20130722BHEP Ipc: A61K 9/20 20060101AFI20130722BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140301 |